21stBio

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Apr 1, 2024	Reshape Biotech	$20.0M Series A	Per Falholt, Astanor Ventures	ACME Capital, Charlie Songhurst, Nicholas Francis, ACME, R7 Partners, Y Combinator

Total Raised

N/A

Valuation

N/A

Key people at 21stBio.

Thomas Nagy

Key people at 21stBio.

Thomas Nagy